CVS Stock's New Low Signals BIG MOVES in the Market

TL;DR

CVS is a huge company with solid cash flow growth and a high dividend payout. The company's financials reveal a decline in profit margin due to recent losses. However, CVS is expected to experience double-digit growth and has the potential to expand its profit margin through its healthcare initiatives.

Transcript

huge company Mo not huge you saw Zero benefit they can easily afford this dividend wow that's a big cash flow growth the thing that's made us so famous so pretty solid CVS hit a 52-week low on January 25th which was just five days ago according to our software it was it was at 84.82 all-time high was all the way back in 2015 and 113 dollars so on t... Read More

Key Insights

• 💐 CVS has a solid cash flow growth despite a decline in profit margin, indicating the company's ability to generate significant revenue.
• 🌸 The difference in PE ratio between CVS and Walgreens suggests that CVS's valuation is higher, potentially due to the recent losses and lower profit margin.
• ✋ CVS's acquisition in the healthcare sector may drive higher profit margin and revenue growth.
• 🙃 The company's stock price may be considered reasonable at current levels, with potential upside if cash flow and profit margin improve.
• ☄️ Analyst estimates suggest that CVS will continue its growth trajectory with double-digit earnings growth in the coming years.
• ❓ CVS's focus on its healthcare initiatives and potential inflation in its products may contribute to revenue growth.
• #️⃣ Share dilution due to acquisitions may impact per-share profit numbers, but growth in overall profit should still benefit investors.

Questions & Answers

Q: Why does CVS have a higher PE ratio compared to Walgreens?

CVS's higher PE ratio can be attributed to the decline in its profit margin, which is half of what it was in the last five years. This decrease in profitability has affected its valuation.

Q: What caused the recent losses for CVS?

CVS experienced a significant loss of $9 billion, resulting in a decrease in profit. The exact reason for this loss can be determined by referring to the company's 10K filing.

Q: Is CVS's revenue growth sustainable?

While CVS's revenue growth has been significant, a conservative estimate would assume a growth rate of around 3-4% in the future. However, the company's initiatives in the healthcare sector may contribute to higher growth.

Q: How are analyst estimates for CVS?

Analysts expect CVS to make $9 per share this year and $13.30 per share in four years, indicating double-digit earnings growth.

Summary & Key Takeaways

• CVS, a top company in the industry, has a market cap of $115 billion and an enterprise value of $258 billion.

• The company's high dividend payout of 2.5% is easily affordable, as its free cash flow last year was $19.5 billion, only eating up around 20% of the five-year average.

• CVS's profit margin has declined, leading to a higher price-to-earnings (PE) ratio of 36 compared to Walgreens' PE ratio of 13.6. However, the company's revenue and cash flow growth are promising.